Evidence explainerResveratrol

Resveratrol Benefits: Mostly Null Results in Human Trials

Resveratrol became famous through red wine and lab studies. In randomized human trials, pooled results for blood pressure, blood sugar, memory and weight are mostly null or very small.

By Kymata Health editorial teamPublished October 9, 2026Last reviewed October 9, 2026

Medical review pending. Written by our editorial team from the studies cited below; a credentialed clinician has not reviewed it yet. Educational only, not medical advice.

Key takeaways

  • Across 6 trials (247 people), resveratrol did not significantly lower blood pressure overall; a subgroup at 150 mg/day or more did show lower systolic pressure [1].
  • In 11 trials (388 people), resveratrol did not change glucose measures in people without diabetes [2].
  • Across 4 trials (226 people), resveratrol had no significant effect on memory or cognitive performance [3].
  • In 28 trials, weight fell by about 0.51 kg, with no significant change in fat mass [4].
  • Lipid meta-analyses disagree: one found lower total and LDL cholesterol, another found no change [5][6].

Safety at a glance

From our Resveratrol monograph. Published interactions and cautions only, each with its source.

Who should be careful

  • People taking prescription medicines. Data on interactions between resveratrol and other therapies are still lacking, according to a 2020 review.[10]
  • High amounts. In older adults with overweight, high amounts raised some blood markers of cardiovascular risk, according to a 2024 systematic review.[9]
  • Before you start. Talk to your pharmacist or clinician before adding this supplement, especially if you take prescription medicines, are pregnant or breastfeeding, or have a chronic health condition.[9]

Full Resveratrol safety section

The evidence, graded

Pulled from our monograph evidence tables. Grades follow our evidence-grading policy.

  • Grade CMixedBlood pressureResveratrol · Meta-analysis · n=247 · 2015 · PMID 24731650No significant overall effect on systolic or diastolic pressure. In the higher-dose subgroup (150 mg/day or more), systolic pressure fell by 11.9 mmHg; meta-regression showed no dose effect.
  • Grade CMixedFasting glucose, insulin and HbA1cResveratrol · Meta-analysis · n=388 · 2014 · PMID 24695890No significant effect on glucose measures in people without diabetes. In people with diabetes, fasting glucose, insulin, HbA1c and insulin resistance fell.
  • Grade CNo effectMemory and cognitive performance; moodResveratrol · Meta-analysis · n=226 · 2018 · PMID 28844841No significant effect on learning, delayed recall, retention or recognition (effect sizes near zero). Two mood-scale items (vigor and fatigue) changed significantly; other mood measures did not.

Blood pressure and cholesterol

A 2015 meta-analysis of 6 trials (247 people) found no significant overall effect on systolic or diastolic pressure [1]. In a subgroup taking 150 mg/day or more, systolic pressure fell by 11.9 mmHg, but meta-regression did not find a dose effect [1].

Another 2015 meta-analysis of 10 trials found no effect on CRP or total cholesterol [6]. A 2022 dose-response meta-analysis did find lower total cholesterol, triglycerides and LDL, with no change in HDL [5].

Blood sugar

In a 2014 meta-analysis of 11 trials (388 people), resveratrol had no significant effect on glucose measures in people without diabetes [2]. In people with diabetes, fasting glucose, insulin and HbA1c fell [2].

A 2020 Cochrane review limited to 3 short trials (50 adults with type 2 diabetes) found neutral effects on HbA1c and fasting glucose, with very low-certainty evidence [7]. So even the diabetes finding is unsettled.

Memory and weight

A 2018 meta-analysis of 4 trials (226 individuals) found no significant effect on memory or cognitive performance; two mood-scale items changed and others did not [3].

A 2019 meta-analysis of 28 trials found weight fell by 0.51 kg and waist by 0.79 cm, with no significant change in fat mass [4].

One reason results may be weak

In a multiple-dose study, trans-resveratrol reached relatively low blood levels even at high doses given six times a day, with high person-to-person variation [8]. For the safety picture, read is resveratrol safe.

Quick answers

Is resveratrol good for skin?

None of the trials in our sources measured skin outcomes from resveratrol supplements [1][3].

Does resveratrol help weight loss?

Only slightly: about 0.51 kg in pooled trials, with no significant change in fat mass [4].

Does resveratrol work better with NR?

In a 6-month trial in people with peripheral artery disease, adding resveratrol did not add benefit to nicotinamide riboside for walking distance [9].

Keep reading

Browse the full Supplement & Nutrient Encyclopedia or all supplement articles.

References

  1. [1]Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials. Clin Nutr, 2015. PMID 24731650
  2. [2]Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr, 2014. PMID 24695890
  3. [3]Effect of resveratrol on cognitive and memory performance and mood: A meta-analysis of 225 patients. Pharmacol Res, 2018. PMID 28844841
  4. [4]Resveratrol supplementation significantly influences obesity measures: a systematic review and dose-response meta-analysis of randomized controlled trials. Obes Rev, 2019. PMID 30515938
  5. [5]The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials. Nutrients, 2022. PMID 36145131
  6. [6]Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol, 2015. PMID 25885871
  7. [7]Resveratrol for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev, 2020. PMID 31978258
  8. [8]Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res, 2009. PMID 19194969
  9. [9]Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nat Commun, 2024. PMID 38871717

Resveratrol and other dietary supplements are not intended to diagnose, treat, cure or prevent any disease, and these statements have not been evaluated by the FDA. Talk to your clinician or pharmacist before starting a supplement, especially if you take prescription medicines. This page has no product or affiliate links.